ArticlePharmaceuticals (Basel, Switzerland)2024

NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy.

Simone Dal Bello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.